# FDA Inspection 1006554 - Reem Ghalib, M.D. - March 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/reem-ghalib-md/c7d33b8e-d4e2-4795-9d5f-94cbf9f31b52
Source feed: FDA_Inspections

> FDA Inspection 1006554 for Reem Ghalib, M.D. on March 17, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006554
- Company Name: Reem Ghalib, M.D.
- Inspection Date: 2017-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 939665 - 2015-08-07](https://www.keypedia.com/records/fda_inspections/reem-ghalib-md/15a931bf-2211-403e-88db-7509df8a5bd2)

Company: https://www.keypedia.com/companies/reem-ghalib-md/ad801f67-98ba-4a1d-a80c-978093aae335

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c